Gene · 10397
Papers3,293
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
161 to 180 of 3,293
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Unleashing the potential of gene signatures as prognostic and predictive tools: A step closer to personalized medicine in hepatocellular carcinoma (HCC). | Cell Biochem Funct | 2024 | 38269520 | PubTator, text mining | PubMed |
| Hypoxia inducible factors inhibit respiratory syncytial virus infection by modulation of nucleolin expression. | iScience | 2024 | 38261926 | PubTator, text mining | PubMed |
| PTEN, ERG, SPINK1, and TFF3 Status and Relationship in a Prostate Cancer Cohort from Jordanian Arab Population. | Medicina (Kaunas) | 2024 | 38256434 | PubTator, text mining | PubMed |
| The TGF-β Family in Glioblastoma. | Int J Mol Sci | 2024 | 38256140 | PubTator, text mining | PubMed |
| Molecular Insights into the Breast and Prostate Cancer Cells in Response to the Change of Extracellular Zinc. | J Oncol | 2024 | 38249992 | PubTator, text mining | PubMed |
Unraveling the underlying pathogenic factors driving nonalcoholic steatohepatitis and hepatocellular carcinoma: an in-depth analysis of prognostically relevant gene signatures in hepatocellular carcinoma. | J Transl Med | 2024 | 38238845 | PubTator, text mining | PubMed |
| The role of serum/glucocorticoid-regulated kinase 1 in brain function following cerebral ischemia. | J Cereb Blood Flow Metab | 2024 | 38235747 | PubTator, text mining | PubMed |
| NDRG1 overcomes resistance to immunotherapy of pancreatic ductal adenocarcinoma through inhibiting ATG9A-dependent degradation of MHC-1. | Drug Resist Updat | 2024 | 38228036 | PubTator, text mining | PubMed |
| The N6-methyladenosine demethylase ALKBH5 regulates the hypoxic HBV transcriptome. | PLoS Pathog | 2024 | 38227578 | PubTator, text mining | PubMed |
| Morphologic and genomic changes of thyroid cancer cell lines exposed to conditions of simulated microgravity. | NPJ Microgravity | 2024 | 38225447 | PubTator, text mining | PubMed |
| A Prognostic Model Based on Cisplatin-Resistance Related Genes in Oral Squamous Cell Carcinoma. | Oral Health Prev Dent | 2024 | 38223960 | PubTator, text mining | PubMed |
| Identification of a vascular invasion-related signature based on lncRNA pairs for predicting prognosis in hepatocellular carcinoma. | BMC Gastroenterol | 2024 | 38221614 | PubTator, text mining | PubMed |
| Novel cellular systems unveil mucosal melanoma initiating cells and a role for PI3K/Akt/mTOR pathway in mucosal melanoma fitness. | J Transl Med | 2024 | 38191367 | PubTator, text mining | PubMed |
| Prognostic biomarker discovery based on proteome landscape of Chinese lung adenocarcinoma. | Clin Proteomics | 2024 | 38182978 | PubTator, text mining | PubMed |
| N6-methyladenosine methylation analysis of long noncoding RNAs and mRNAs in 5-FU-resistant colon cancer cells. | Epigenetics | 2024 | 38145548 | PubTator, text mining | PubMed |
| UBE2J1 is the E2 ubiquitin-conjugating enzyme regulating androgen receptor degradation and antiandrogen resistance. | Oncogene | 2024 | 38030789 | PubTator, text mining | PubMed |
| Identification of hypoxia-related gene signatures based on multi-omics analysis in lung adenocarcinoma. | J Cell Mol Med | 2024 | 38013642 | PubTator, text mining | PubMed |
| LINC02561 promotes metastasis in HCC via HIF1-α/NDRG1/UPF1 axis. | Gene | 2024 | 38013127 | PubTator, text mining | PubMed |
| Optical genome mapping reveals balanced and unbalanced genetic changes associated with tumor-forming potential in an early-stage prostate cancer epithelial subline (M2205). | Mol Genet Genomic Med | 2024 | 37902189 | PubTator, text mining | PubMed |
| Proteomics on malignant pleural effusions reveals ERα loss in metastatic breast cancer associates with SGK1-NDRG1 deregulation. | Mol Oncol | 2024 | 37854018 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/10397/papers?page=9